October 7, 2026
Lantern Pharma Wins Taiwan Approvals for Phase 2 HARMONIC Trial of LP-300 in Lung Cancer
October 7, 2026
Quantum BioPharma Taps Thermo Fisher for Phase 2 Lucid-MS Trial, Advancing Novel Neuroprotective Approach
October 7, 2026
VERAXA Biotech Advances FDA-Aligned Methods to Cut Animal Testing in Cancer Drug Development
October 7, 2026
Quantum BioPharma Taps Thermo Fisher to Launch Phase 2 Trial of Lucid-MS for Progressive MS
October 7, 2026
C60 Power Marks National C60 Day on October 9 with Education, Community Stories, and Storewide Sale
October 6, 2026
Quantum BioPharma Taps Thermo Fisher for Lucid-MS Phase 2 Trial in Multiple Sclerosis
October 6, 2026
Telomir Pharmaceuticals Secures $5.6 Million PIPE Financing to Advance Telomir-Zn Clinical Program
October 6, 2026
Earth Science Tech’s Real Estate Subsidiary Avenvi Drives Synergies and Revenue Growth
October 6, 2026
NanoViricides to Present at NIBA Conference as NV-387 Advances in Ebola and Mpox Trials
October 6, 2026
Skull’s Hidden Lymph Node-Like Structures May Give Brain a Local Immune Defense, Study Finds
October 6, 2026
Okogen Secures CDSCO Authorization for EMERALD Phase 1/2 Study of Treyegen™ (OKG-0303) for Acute Infectious Conjunctivitis
October 6, 2026
Kairos Pharma’s ENV-105 Shows Significant Progression-Free Survival Benefit in Phase 2 Prostate Cancer Trial
October 6, 2026
AXIM Biotechnologies Submits 510(k) to FDA for Rapid Point-of-Care Tear Lactoferrin Test for Dry Eye Disease
October 6, 2026
GeoVax to Present Single-Dose MVA Vaccine and Scalable Manufacturing Advances at World Vaccine Congress Europe 2026
October 6, 2026
BFCH and NEXT10 Unveil Plan to Build Scalable Health and Wellness Platform with 62 Wellness Centers
October 5, 2026
Oncotelic Opens BIO REBOOT Registration and Announces PDAOAI Presentations at Drug Discovery 2026
October 5, 2026
NanoViricides Advances Phase II Trial of Oral Ebola Treatment as Congo Outbreak Continues
October 5, 2026
HeartBeam Receives FDA Breakthrough Device Designation for At-Home Heart Attack Assessment
October 5, 2026
Certified-PEP Highlights U.S.-Made Research Peptide Portfolio with Independent Batch Testing
October 5, 2026
Biotech Leader Philip Ashton-Rickardt Says Scientific Success Hinges on Knowing When to Pivot
October 4, 2026
Flushie Pre-Toilet Spray Gains National Recognition After International Housewares Show Appearance
October 2, 2026
SS Innovations International Expands SSi Mantra Surgical Robot Globally as Revenue Climbs 39.4%
October 2, 2026
Healthspan Action Coalition and Italian Partners Launch Global Collaboration to Extend Healthy Lifespan
October 2, 2026
Healthspan Action Coalition Launches Italy-U.S. Longevity Alliance to Accelerate Healthy Aging
October 1, 2026
Perpetuals.com’s UpsideOnly Platform Hits 600,000 Users as Risk-Free Trading Gains Traction
October 1, 2026
Avatar Medical Integrates Patient-Specific 3D Imaging with Epic EHR to Streamline Clinical Workflows
October 1, 2026
HealthLynked Selects DRCARE247 as Telemedicine Partner to Integrate Virtual Care into Its Platform
October 1, 2026
Incannex Healthcare’s Lead Cannabinoid Drug Enters Active Clinical Execution as Stonegate Updates Coverage
October 1, 2026
Lantern Pharma Closes $4 Million Registered Direct Offering to Advance AI-Driven Oncology Pipeline
October 1, 2026
New Medical Thriller ‘The Vena Protocol: First Blood’ Exposes the Deadly Cost of Data Manipulation
October 1, 2026
New Medical Thriller The Vena Protocol: First Blood Examines Clinical Trial Integrity
September 30, 2026
Onco-Innovations Advances ONC010 Toward Clinical Trials with Manufacturing Scale-Up and $5M Financing
September 30, 2026
Quantum BioPharma Advances Lucid-MS to Phase 2 Trial, Highlights Royalty Stream from unbuzzd
September 30, 2026
Gold Recovers Modestly as Investors Eye U.S. Economic Data and Middle East Tensions
September 30, 2026
Silo Pharma’s QwikAgents Adds NVIDIA Support and Hermes Runtime, Expanding AI Agent Platform
September 30, 2026
Quantum BioPharma Co-Founder Details Lucid-MS Phase 2 Trial and unbuzzd Commercial Prospects on BioMedWire Podcast
September 30, 2026
Vanderbilt Scientist Annet Kirabo to Receive 2026 Joseph A. Vita Award for Immune-Hypertension Research
September 30, 2026
BIOT Appointed Authorized Representative for IN01 Cancer Immunotherapy in Japan and China
